Skip to main content
For COVID-19 vaccine updates, please
review our information guide
and
sign up for Connect
. Continue your routine care with us by scheduling an
in-person appointment
or
Video Visit
.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Myeloma Center
Explore this Website
Home
About Us
Toggle menu options
Our Team
Patient Testimonials
News
For Patients
Toggle menu options
Health Information Library and Patient Resources
Support Groups and Helpful Links
Frequently Asked Questions
Your First Visit
Toggle menu options
Self-Referral
Lab Work/Procedures
Referring Physicians
Toggle menu options
Refer a Patient
Research and Clinical Trials
Toggle menu options
Basic and Translational Research
Bibliography
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
For Patients
Referring Physicians
Research and Clinical Trials
Contact Us
Home
Bibliography
Bibliography
Basic and Translational Research
Bibliography
Bibliography
Found 56 results
Author
Title
Type
[
Year
]
2017
Mark TM
,
Guarneri D
,
Forsberg P
,
Rossi A
,
Pearse R
,
Perry A
,
Pekle K
,
Tegnestam L
,
Greenberg J
,
Shore T
et al.
. 2017.
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
.
Biol Blood Marrow Transplant. 23(6):930-937.
Ou Y
,
Doshi S
,
Nguyen A
,
Jonsson F
,
Aggarwal S
,
Rajangam K
,
Dimopoulos MA
,
A Stewart K
,
Badros A
,
Papadopoulos KP
et al.
. 2017.
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.
.
J Clin Pharmacol. 57(5):663-677.
2018
Goldschmidt H
,
Moreau P
,
Ludwig H
,
Niesvizky R
,
Chng W-J
,
Joshua D
,
Weisel K
,
Spencer A
,
Orlowski RZ
,
Feng S
et al.
. 2018.
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study.
.
Leuk Lymphoma. 59(6):1364-1374.
Reich-Slotky R
,
Makhani SS
,
Vasovic LV
,
Pearse RN
,
Rossi A
,
Philips A
,
Cushing MM
,
Singh AD
,
van-Besien K
. 2018.
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
.
Leuk Lymphoma. :1-7.
Wei X
,
M Calvo-Vidal N
,
Chen S
,
Wu G
,
Revuelta MV
,
Sun J
,
Zhang J
,
Walsh MF
,
Nichols KE
,
Joseph V
et al.
. 2018.
Germline Lysine-Specific Demethylase 1 () Mutations Confer Susceptibility to Multiple Myeloma.
.
Cancer Res. 78(10):2747-2759.
Singh AD
,
Parmar S
,
Patel K
,
Shah S
,
Shore T
,
Gergis U
,
Mayer S
,
Phillips A
,
Hsu J-M
,
Niesvizky R
et al.
. 2018.
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
.
Biol Blood Marrow Transplant. 24(2):288-293.
« first
‹ previous
1
2
3
(current)